P53 pathway is a major determinant in the radiosensitizing effect of Palbociclib: Implication in cancer therapy
Autor: | Fernández-Aroca, D.M., Roche, O., Sabater, S., Pascual-Serra, R., Ortega-Muelas, M., Sánchez Pérez, I., Belandia, B., Ruiz-Hidalgo, M.J., Sánchez-Prieto, R. |
---|---|
Zdroj: | In Cancer Letters 1 June 2019 451:23-33 |
Databáze: | ScienceDirect |
Externí odkaz: |